Keywords: Emergent BioSolutions, Temasek, Joint venture, Research, Pandemic flu, Monoclonal antibody

Emergent BioSolutions and Temasek set up JV to develop pandemic flu vaccine and therapeutic

Article | 11 August 2010

Print This

Singapore-based Temasek Life Science Ventures Pte and the USA’s Emergent BioSolutions have agreed to form EPIC BIO Pte Ltd, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in